Surgery for Borderline Resectable Pancreatic Ductal Adenocarcinoma Preoperative Planning, Technical Considerations, and Building a Program

被引：0
|
作者：
Drake, Justin [1 ]
Anaya, Daniel A. [1 ,2 ]
Fleming, Jason B. [1 ,3 ]
Denbo, Jason W. [1 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Gastrointestinal Oncol, Tampa, FL 33612 USA
[2] UT Southwestern Med Ctr, Div GI Surg, Dallas, TX USA
[3] UT Southwestern Med Ctr, Dept Surg, Dallas, TX USA
来源：
SURGICAL CLINICS OF NORTH AMERICA | 2024年 / 104卷 / 05期
关键词：
Ancreaticoduodenectomy; Periampullary region; Oncologic therapy; Pancreatic surgery; CONSENSUS STATEMENT; CANCER; PANCREATICODUODENECTOMY; CARCINOMA; AMPULLA;
D O I：
10.1016/j.suc.2024.07.001
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：1031 / 1048
页数：18
相关论文
共 50 条
  • [41] A Prospective Phase II Trial of Neoadjuvant S-1 with Concurrent Hypofractionated Radiotherapy in Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma
    Okano, Keiichi
    Suto, Hironobu
    Oshima, Minoru
    Maeda, Eri
    Yamamoto, Naoki
    Kakinoki, Keitaro
    Kamada, Hideki
    Masaki, Tsutomu
    Takahashi, Shigeo
    Shibata, Toru
    Suzuki, Yasuyuki
    ANNALS OF SURGICAL ONCOLOGY, 2017, 24 (09) : 2777 - 2784
  • [42] Network meta-analysis comparing neoadjuvant chemoradiation, neoadjuvant chemotherapy and upfront surgery in patients with resectable, borderline resectable, and locally advanced pancreatic ductal adenocarcinoma
    Hu, Qiancheng
    Wang, Dan
    Chen, Ye
    Li, Xiaofen
    Cao, Peng
    Cao, Dan
    RADIATION ONCOLOGY, 2019, 14 (1)
  • [43] Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma
    Zhuang, Jiaru
    Wang, Shan
    Wang, Yuan
    Wu, Yibo
    Hu, Renjing
    BMC CANCER, 2024, 24 (01)
  • [44] Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma
    Acuna-Villaorduna, Ana
    Shankar, Viswanathan
    Wysota, Michael
    Jirgal, Amanda
    Kabarriti, Rafi
    Bellemare, Sarah
    Goldman, Inessa
    Kaubisch, Andreas
    Aparo, Santiago
    Goel, Sanjay
    Chuy, Jennifer
    CANCER CONTROL, 2022, 29
  • [45] Racial Disparity in Pancreatoduodenectomy for Borderline Resectable Pancreatic Adenocarcinoma
    Molina, George
    Clancy, Thomas E.
    Tsai, Thomas C.
    Lam, Miranda
    Wang, Jiping
    ANNALS OF SURGICAL ONCOLOGY, 2021, 28 (02) : 1088 - 1096
  • [46] Borderline resectable pancreatic adenocarcinoma, is conversion therapy realistic?
    Kelly, Ciara M.
    El Bassiouni, Mazen
    Bennett, Michael W.
    Crush, Lee
    McEneaney, Peter
    O'Suilleabhain, Criostoir
    Power, Derek G.
    ACTA ONCOLOGICA, 2014, 53 (09) : 1268 - +
  • [47] Metabolite Changes Associated with Resectable Pancreatic Ductal Adenocarcinoma
    Mcdonnell, Declan
    Afolabi, Paul R.
    Niazi, Umar
    Wilding, Sam
    Griffiths, Gareth O.
    Swann, Jonathan R.
    Byrne, Christopher D.
    Hamady, Zaed Z.
    CANCERS, 2025, 17 (07)
  • [48] Commentary on Neoadjuvant Versus Surgery First Approach in Resectable Pancreatic Ductal Adenocarcinoma Reply
    Saharia, Ashish
    Potter, Lucy
    Baio, Flavio
    Elshawwaf, Mahmoud
    Abdelrahim, Maen
    Heyne, Kirk
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2020, 43 (10): : 753 - 754
  • [49] Gemcitabine-Based Neoadjuvant Treatment in Borderline Resectable Pancreatic Ductal Adenocarcinoma: A Meta-Analysis of Individual Patient Data
    Giovinazzo, Francesco
    Soggiu, Fiammetta
    Jang, Jin-Young
    Versteijne, Eva
    van Tienhoven, Geertjan
    van Eijck, Casper H.
    Han, Youngmin
    Choi, Seong Ho
    Kang, Chang Moo
    Zalupski, Mark
    Ahmad, Hasham
    Yentz, Sarah
    Helton, Scott
    Rose, J. Bart
    Takishita, Chie
    Nagakawa, Yuichi
    Abu Hilal, Mohammad
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [50] Untargeted metabolomics characterization of the resectable pancreatic ductal adenocarcinoma
    Cao, Ying-Ying
    Guo, Kai
    Zhao, Rui
    Li, Yuan
    Lv, Xiao-Jing
    Lu, Zi-Peng
    Tian, Lei
    Ren, Shuai
    Wang, Zhong-Qiu
    DIGITAL HEALTH, 2023, 9
12345